Global Laboratory-developed Testing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 07-Sep-2022
No. of pages: 106
Inquire Before Buying

Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vitro diagnostics (IVDs)4. In 2010, the FDA began work on developing a proposed framework for future LDT oversight. Released in 2014, the draft guidance sparked an intense debate over potential LDT regulation. While the proposed guidance has not been implemented, many questions regarding LDT oversight remain unresolved.

A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed, manufactured and used within a single laboratory.

LDTs can be used to measure or detect a wide variety of analytes (substances such as proteins, chemical compounds like glucose or cholesterol, or DNA), in a sample taken from a human body. Some LDTs are relatively simple tests that measure single analytes, such as a test that measures the level of sodium. Other LDTs are complex and may measure or detect one or more analytes. For example, some tests can detect many DNA variations from a single blood sample, which can be used to help diagnose a genetic disease. Various levels of chemicals can be measured to help diagnose a patient's state of health, such as levels of cholesterol or sodium.

While the uses of an LDT are often the same as the uses of FDA-cleared or approved in vitro diagnostic tests, some labs may choose to offer their own test. For example, a hospital lab may run its own vitamin D assay, even though there is an FDA-cleared test for vitamin D currently on the market.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Laboratory-developed Testing market is projected to reach US$ 4582.6 million by 2028 from an estimated US$ 3663.8 million in 2022, at a CAGR of 3.8% during 2023 and 2028.

The leading players in laboratory-developed testing include Quest Diagnostics, Roche, Illumina, Qiagen, and Eurofins, with the top three accounting for approximately 15% of the market.

North America is the largest market with more than 65% of the market, followed by Europe with about 15%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Laboratory-developed Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Laboratory-developed Testing.

The Laboratory-developed Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Laboratory-developed Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Laboratory-developed Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Adaptive Biotechnologies Corporation

- Quest Diagnostics

- Roche

- Illumina

- Qiagen

- Eurofins

- Guardant Health

- Biotheranostics

- Adaptive Biotechnologies

- Rosetta Genomics

- Biodesix

- Helix

Product Type Insights

Global markets are presented by Laboratory-developed Testing type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Laboratory-developed Testing are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Laboratory-developed Testing Segment by Type

- Commercial Service

- R&D

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Laboratory-developed Testing market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Laboratory-developed Testing market.

Laboratory-developed Testing Segment by Application

- Genetic Testing

- Oncology

- Infectious Disease

- Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Laboratory-developed Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Laboratory-developed Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Laboratory-developed Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Laboratory-developed Testing industry.

This report helps stakeholders to gain insights into which regions to target globally.

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Laboratory-developed Testing.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Global Laboratory-developed Testing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Laboratory-developed Testing Product Introduction
1.2 Market by Type
1.2.1 Global Laboratory-developed Testing Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Commercial Service
1.2.3 R&D
1.3 Market by Application
1.3.1 Global Laboratory-developed Testing Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Genetic Testing
1.3.3 Oncology
1.3.4 Infectious Disease
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Laboratory-developed Testing Market Size Estimates and Forecasts
2.2 Laboratory-developed Testing Market Size by Region: 2022 Versus 2028
2.2.1 Global Laboratory-developed Testing Revenue by Region: 2017-2022
2.2.2 Global Laboratory-developed Testing Revenue Forecast by Region (2023-2028)
2.2.3 Global Laboratory-developed Testing Revenue Market Share by Region (2017-2028)
3 Global Laboratory-developed Testing by Company
3.1 Global Laboratory-developed Testing Revenue by Company (2017-2022)
3.2 Global Laboratory-developed Testing Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Laboratory-developed Testing Companies around the World: Ranking by Revenue
3.3.2 Global Laboratory-developed Testing Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Laboratory-developed Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Laboratory-developed Testing Companies Headquarters & Product Type
3.4.1 Laboratory-developed Testing Companies Headquarters
3.4.2 Global Laboratory-developed Testing Companies Product & Service
3.4.3 Date of International Companies Enter into Laboratory-developed Testing Market
3.5 Global Laboratory-developed Testing Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Adaptive Biotechnologies Corporation
4.1.1 Adaptive Biotechnologies Corporation Corporation Information
4.1.2 Adaptive Biotechnologies Corporation Description, Business Overview
4.1.3 Adaptive Biotechnologies Corporation Laboratory-developed Testing Products Offered
4.1.4 Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue and Gross Margin (2017-2022)
4.1.5 Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue by Product in 2021
4.1.6 Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue by Application in 2021
4.1.7 Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue by Geographic Area in 2021
4.1.8 Adaptive Biotechnologies Corporation Recent Developments
4.2 Quest Diagnostics
4.2.1 Quest Diagnostics Corporation Information
4.2.2 Quest Diagnostics Description, Business Overview
4.2.3 Quest Diagnostics Laboratory-developed Testing Products Offered
4.2.4 Quest Diagnostics Laboratory-developed Testing Revenue and Gross Margin (2017-2022)
4.2.5 Quest Diagnostics Laboratory-developed Testing Revenue by Product in 2021
4.2.6 Quest Diagnostics Laboratory-developed Testing Revenue by Application in 2021
4.2.7 Quest Diagnostics Laboratory-developed Testing Revenue by Geographic Area in 2021
4.2.8 Quest Diagnostics Recent Developments
4.3 Roche
4.3.1 Roche Corporation Information
4.3.2 Roche Description, Business Overview
4.3.3 Roche Laboratory-developed Testing Products Offered
4.3.4 Roche Laboratory-developed Testing Revenue and Gross Margin (2017-2022)
4.3.5 Roche Laboratory-developed Testing Revenue by Product in 2021
4.3.6 Roche Laboratory-developed Testing Revenue by Application in 2021
4.3.7 Roche Laboratory-developed Testing Revenue by Geographic Area in 2021
4.3.8 Roche Recent Developments
4.4 Illumina
4.4.1 Illumina Corporation Information
4.4.2 Illumina Description, Business Overview
4.4.3 Illumina Laboratory-developed Testing Products Offered
4.4.4 Illumina Laboratory-developed Testing Revenue and Gross Margin (2017-2022)
4.4.5 Illumina Laboratory-developed Testing Revenue by Product in 2021
4.4.6 Illumina Laboratory-developed Testing Revenue by Application in 2021
4.4.7 Illumina Laboratory-developed Testing Revenue by Geographic Area in 2021
4.4.8 Illumina Recent Developments
4.5 Qiagen
4.5.1 Qiagen Corporation Information
4.5.2 Qiagen Description, Business Overview
4.5.3 Qiagen Laboratory-developed Testing Products Offered
4.5.4 Qiagen Laboratory-developed Testing Revenue and Gross Margin (2017-2022)
4.5.5 Qiagen Laboratory-developed Testing Revenue by Product in 2021
4.5.6 Qiagen Laboratory-developed Testing Revenue by Application in 2021
4.5.7 Qiagen Laboratory-developed Testing Revenue by Geographic Area in 2021
4.5.8 Qiagen Recent Developments
4.6 Eurofins
4.6.1 Eurofins Corporation Information
4.6.2 Eurofins Description, Business Overview
4.6.3 Eurofins Laboratory-developed Testing Products Offered
4.6.4 Eurofins Laboratory-developed Testing Revenue and Gross Margin (2017-2022)
4.6.5 Eurofins Laboratory-developed Testing Revenue by Product in 2021
4.6.6 Eurofins Laboratory-developed Testing Revenue by Application in 2021
4.6.7 Eurofins Laboratory-developed Testing Revenue by Geographic Area in 2021
4.6.8 Eurofins Recent Development
4.7 Guardant Health
4.7.1 Guardant Health Corporation Information
4.7.2 Guardant Health Description, Business Overview
4.7.3 Guardant Health Laboratory-developed Testing Products Offered
4.7.4 Guardant Health Laboratory-developed Testing Revenue and Gross Margin (2017-2022)
4.7.5 Guardant Health Laboratory-developed Testing Revenue by Product in 2021
4.7.6 Guardant Health Laboratory-developed Testing Revenue by Application in 2021
4.7.7 Guardant Health Laboratory-developed Testing Revenue by Geographic Area in 2021
4.7.8 Guardant Health Recent Development
4.8 Biotheranostics
4.8.1 Biotheranostics Corporation Information
4.8.2 Biotheranostics Description, Business Overview
4.8.3 Biotheranostics Laboratory-developed Testing Products Offered
4.8.4 Biotheranostics Laboratory-developed Testing Revenue and Gross Margin (2017-2022)
4.8.5 Biotheranostics Laboratory-developed Testing Revenue by Product in 2021
4.8.6 Biotheranostics Laboratory-developed Testing Revenue by Application in 2021
4.8.7 Biotheranostics Laboratory-developed Testing Revenue by Geographic Area in 2021
4.8.8 Biotheranostics Recent Development
4.9 Adaptive Biotechnologies
4.9.1 Adaptive Biotechnologies Corporation Information
4.9.2 Adaptive Biotechnologies Description, Business Overview
4.9.3 Adaptive Biotechnologies Laboratory-developed Testing Products Offered
4.9.4 Adaptive Biotechnologies Laboratory-developed Testing Revenue and Gross Margin (2017-2022)
4.9.5 Adaptive Biotechnologies Laboratory-developed Testing Revenue by Product in 2021
4.9.6 Adaptive Biotechnologies Laboratory-developed Testing Revenue by Application in 2021
4.9.7 Adaptive Biotechnologies Laboratory-developed Testing Revenue by Geographic Area in 2021
4.9.8 Adaptive Biotechnologies Recent Development
4.10 Rosetta Genomics
4.10.1 Rosetta Genomics Corporation Information
4.10.2 Rosetta Genomics Description, Business Overview
4.10.3 Rosetta Genomics Laboratory-developed Testing Products Offered
4.10.4 Rosetta Genomics Laboratory-developed Testing Revenue and Gross Margin (2017-2022)
4.10.5 Rosetta Genomics Laboratory-developed Testing Revenue by Product in 2021
4.10.6 Rosetta Genomics Laboratory-developed Testing Revenue by Application in 2021
4.10.7 Rosetta Genomics Laboratory-developed Testing Revenue by Geographic Area in 2021
4.10.8 Rosetta Genomics Recent Development
4.11 Biodesix
4.11.1 Biodesix Corporation Information
4.11.2 Biodesix Description, Business Overview
4.11.3 Biodesix Laboratory-developed Testing Products Offered
4.11.4 Biodesix Laboratory-developed Testing Revenue and Gross Margin (2017-2022)
4.11.5 Biodesix Laboratory-developed Testing Revenue by Product in 2021
4.11.6 Biodesix Laboratory-developed Testing Revenue by Application in 2021
4.11.7 Biodesix Laboratory-developed Testing Revenue by Geographic Area in 2021
4.11.8 Biodesix Recent Development
4.12 Helix
4.12.1 Helix Corporation Information
4.12.2 Helix Description, Business Overview
4.12.3 Helix Laboratory-developed Testing Products Offered
4.12.4 Helix Laboratory-developed Testing Revenue and Gross Margin (2017-2022)
4.12.5 Helix Laboratory-developed Testing Revenue by Product in 2021
4.12.6 Helix Laboratory-developed Testing Revenue by Application in 2021
4.12.7 Helix Laboratory-developed Testing Revenue by Geographic Area in 2021
4.12.8 Helix Recent Development
5 Breakdown Data by Type
5.1 Global Laboratory-developed Testing Revenue by Type (2017-2022)
5.2 Global Laboratory-developed Testing Revenue Forecast by Type (2023-2028)
5.3 Laboratory-developed Testing Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Laboratory-developed Testing Revenue by Application (2017-2022)
6.2 Global Laboratory-developed Testing Revenue Forecast by Application (2023-2028)
6.3 Laboratory-developed Testing Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Laboratory-developed Testing Market Size YoY Growth 2017-2028
7.2 North America Laboratory-developed Testing Market Facts & Figures by Country (2017-2028)
7.3 North America Laboratory-developed Testing Revenue by Type (2017-2022)
7.4 North America Laboratory-developed Testing Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Laboratory-developed Testing Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Laboratory-developed Testing Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Laboratory-developed Testing Revenue by Type (2017-2022)
8.4 Asia-Pacific Laboratory-developed Testing Revenue by Application (2017-2022)
9 Europe
9.1 Europe Laboratory-developed Testing Market Size YoY Growth 2017-2028
9.2 Europe Laboratory-developed Testing Market Facts & Figures by Country (2017-2028)
9.3 Europe Laboratory-developed Testing Revenue by Type (2017-2022)
9.4 Europe Laboratory-developed Testing Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Laboratory-developed Testing Market Size YoY Growth 2017-2028
10.2 Latin America Laboratory-developed Testing Market Facts & Figures by Country (2017-2028)
10.3 Latin America Laboratory-developed Testing Revenue by Type (2017-2022)
10.4 Latin America Laboratory-developed Testing Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Laboratory-developed Testing Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Laboratory-developed Testing Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Laboratory-developed Testing Revenue by Type (2017-2022)
11.4 Middle East and Africa Laboratory-developed Testing Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Laboratory-developed Testing Supply Chain Analysis
12.2 Laboratory-developed Testing Key Raw Materials and Upstream Suppliers
12.3 Laboratory-developed Testing Clients Analysis
12.4 Laboratory-developed Testing Sales Channel and Sales Model Analysis
12.4.1 Laboratory-developed Testing Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Laboratory-developed Testing Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Laboratory-developed Testing Distributors
13 Market Dynamics
13.1 Laboratory-developed Testing Industry Trends
13.2 Laboratory-developed Testing Market Drivers
13.3 Laboratory-developed Testing Market Challenges
13.4 Laboratory-developed Testing Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Laboratory-developed Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Companies of Commercial Service
Table 3. Major Companies of R&D
Table 4. Global Laboratory-developed Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Laboratory-developed Testing Market Size by Region (US$ Million): 2022 VS 2028
Table 6. Global Laboratory-developed Testing Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Laboratory-developed Testing Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 8. Laboratory-developed Testing Revenue by Company (2017-2022) & (US$ Million)
Table 9. Laboratory-developed Testing Revenue Share by Company (2017-2022)
Table 10. Ranking of Global Top Laboratory-developed Testing Players by Revenue (US$ Million) in 2021
Table 11. Global Laboratory-developed Testing Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 12. Global Laboratory-developed Testing by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Laboratory-developed Testing as of 2021)
Table 13. Global Laboratory-developed Testing Companies Headquarters
Table 14. Global Laboratory-developed Testing Companies Product & Service
Table 15. Date of International Companies Enter into Laboratory-developed Testing Market
Table 16. Global Laboratory-developed Testing Mergers & Acquisitions, Expansion Plans
Table 17. Adaptive Biotechnologies Corporation Corporation Information
Table 18. Adaptive Biotechnologies Corporation Description and Business Overview
Table 19. Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2017-2022)
Table 20. Adaptive Biotechnologies Corporation Laboratory-developed Testing Product
Table 21. Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Product in 2021
Table 22. Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Application in 2021
Table 23. Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2021
Table 24. Adaptive Biotechnologies Corporation Recent Development
Table 25. Quest Diagnostics Corporation Information
Table 26. Quest Diagnostics Description and Business Overview
Table 27. Quest Diagnostics Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2017-2022)
Table 28. Quest Diagnostics Laboratory-developed Testing Product
Table 29. Quest Diagnostics Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Product in 2021
Table 30. Quest Diagnostics Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Application in 2021
Table 31. Quest Diagnostics Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2021
Table 32. Quest Diagnostics Recent Development
Table 33. Roche Corporation Information
Table 34. Roche Description and Business Overview
Table 35. Roche Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2017-2022)
Table 36. Roche Laboratory-developed Testing Product
Table 37. Roche Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Product in 2021
Table 38. Roche Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Application in 2021
Table 39. Roche Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2021
Table 40. Roche Recent Development
Table 41. Illumina Corporation Information
Table 42. Illumina Description and Business Overview
Table 43. Illumina Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2017-2022)
Table 44. Illumina Laboratory-developed Testing Product
Table 45. Illumina Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Product in 2021
Table 46. Illumina Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Application in 2021
Table 47. Illumina Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2021
Table 48. Illumina Recent Development
Table 49. Qiagen Corporation Information
Table 50. Qiagen Description and Business Overview
Table 51. Qiagen Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2017-2022)
Table 52. Qiagen Laboratory-developed Testing Product
Table 53. Qiagen Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Product in 2021
Table 54. Qiagen Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Application in 2021
Table 55. Qiagen Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2021
Table 56. Qiagen Recent Development
Table 57. Eurofins Corporation Information
Table 58. Eurofins Description and Business Overview
Table 59. Eurofins Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2017-2022)
Table 60. Eurofins Laboratory-developed Testing Product
Table 61. Eurofins Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Product in 2021
Table 62. Eurofins Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Application in 2021
Table 63. Eurofins Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2021
Table 64. Guardant Health Corporation Information
Table 65. Guardant Health Description and Business Overview
Table 66. Guardant Health Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2017-2022)
Table 67. Guardant Health Laboratory-developed Testing Product
Table 68. Guardant Health Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Product in 2021
Table 69. Guardant Health Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Application in 2021
Table 70. Guardant Health Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2021
Table 71. Biotheranostics Corporation Information
Table 72. Biotheranostics Description and Business Overview
Table 73. Biotheranostics Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2017-2022)
Table 74. Biotheranostics Laboratory-developed Testing Product
Table 75. Biotheranostics Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Product in 2021
Table 76. Biotheranostics Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Application in 2021
Table 77. Biotheranostics Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2021
Table 78. Adaptive Biotechnologies Corporation Information
Table 79. Adaptive Biotechnologies Description and Business Overview
Table 80. Adaptive Biotechnologies Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2017-2022)
Table 81. Adaptive Biotechnologies Laboratory-developed Testing Product
Table 82. Adaptive Biotechnologies Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Product in 2021
Table 83. Adaptive Biotechnologies Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Application in 2021
Table 84. Adaptive Biotechnologies Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2021
Table 85. Rosetta Genomics Corporation Information
Table 86. Rosetta Genomics Description and Business Overview
Table 87. Rosetta Genomics Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2017-2022)
Table 88. Rosetta Genomics Laboratory-developed Testing Product
Table 89. Rosetta Genomics Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Product in 2021
Table 90. Rosetta Genomics Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Application in 2021
Table 91. Rosetta Genomics Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2021
Table 92. Biodesix Corporation Information
Table 93. Biodesix Description and Business Overview
Table 94. Biodesix Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2017-2022)
Table 95. Biodesix Laboratory-developed Testing Product
Table 96. Biodesix Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Product in 2021
Table 97. Biodesix Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Application in 2021
Table 98. Biodesix Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2021
Table 99. Helix Corporation Information
Table 100. Helix Description and Business Overview
Table 101. Helix Laboratory-developed Testing Revenue (US$ Million) and Gross Margin (2017-2022)
Table 102. Helix Laboratory-developed Testing Product
Table 103. Helix Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Product in 2021
Table 104. Helix Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Application in 2021
Table 105. Helix Laboratory-developed Testing Revenue Proportion of Laboratory-developed Testing by Geographic Area in 2021
Table 106. Global Laboratory-developed Testing Revenue by Type (2017-2022) & (US$ Million)
Table 107. Global Laboratory-developed Testing Revenue by Application (2017-2022) & (US$ Million)
Table 108. Global Laboratory-developed Testing Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 109. North America Laboratory-developed Testing Revenue by Country (2017-2022) & (US$ Million)
Table 110. North America Laboratory-developed Testing Revenue by Country (2023-2028) & (US$ Million)
Table 111. North America Laboratory-developed Testing Revenue by Type (2017-2022) & (US$ Million)
Table 112. North America Laboratory-developed Testing Revenue by Application (2017-2022) & (US$ Million)
Table 113. Asia-Pacific Laboratory-developed Testing Revenue by Region (2017-2028) & (US$ Million)
Table 114. Asia-Pacific Laboratory-developed Testing Revenue by Region (2023-2028) & (US$ Million)
Table 115. Asia-Pacific Laboratory-developed Testing Revenue by Type (2017-2022) & (US$ Million)
Table 116. Asia-Pacific Laboratory-developed Testing Revenue by Application (2017-2022) & (US$ Million)
Table 117. Europe Laboratory-developed Testing Revenue by Country (2017-2022) & (US$ Million)
Table 118. Europe Laboratory-developed Testing Revenue by Country (2023-2028) & (US$ Million)
Table 119. Europe Laboratory-developed Testing Revenue by Type (2017-2022) & (US$ Million)
Table 120. Europe Laboratory-developed Testing Revenue by Application (2017-2022) & (US$ Million)
Table 121. Latin America Laboratory-developed Testing Revenue by Country (2017-2022) & (US$ Million)
Table 122. Latin America Laboratory-developed Testing Revenue by Country (2023-2028) & (US$ Million)
Table 123. Latin America Laboratory-developed Testing Revenue by Type (2017-2022) & (US$ Million)
Table 124. Latin America Laboratory-developed Testing Revenue by Application (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Laboratory-developed Testing Revenue by Country (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Laboratory-developed Testing Revenue by Country (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Laboratory-developed Testing Revenue by Type (2017-2022) & (US$ Million)
Table 128. Middle East and Africa Laboratory-developed Testing Revenue by Application (2017-2022) & (US$ Million)
Table 129. Laboratory-developed Testing Key Raw Materials, Industry Status and Trend
Table 130. Laboratory-developed Testing Key Raw Materials and Upstream Suppliers
Table 131. Laboratory-developed Testing Clients Status and Trend
Table 132. Laboratory-developed Testing Typical Clients
Table 133. Laboratory-developed Testing Distributors
Table 134. Laboratory-developed Testing Market Trends
Table 135. Laboratory-developed Testing Market Drivers
Table 136. Laboratory-developed Testing Market Challenges
Table 137. Laboratory-developed Testing Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Laboratory-developed Testing Product Picture
Figure 2. Global Laboratory-developed Testing Revenue Market Share by Type in 2021 & 2028
Figure 3. Commercial Service Product Picture
Figure 4. R&D Product Picture
Figure 5. Global Laboratory-developed Testing Revenue Market Share by Application in 2021 & 2028
Figure 6. Genetic Testing
Figure 7. Oncology
Figure 8. Infectious Disease
Figure 9. Others
Figure 10. Laboratory-developed Testing Report Years Considered
Figure 11. Global Laboratory-developed Testing Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Laboratory-developed Testing Market Size 2017-2028 (US$ Million)
Figure 13. Global Laboratory-developed Testing Market Size Market Share by Region: 2022 Versus 2028
Figure 14. Global Laboratory-developed Testing Revenue Market Share by Region (2017-2028)
Figure 15. Laboratory-developed Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Laboratory-developed Testing Revenue Market Share Forecast by Type (2017-2028)
Figure 17. Global Laboratory-developed Testing Revenue Market Share Forecast by Application (2017-2028)
Figure 18. North America Laboratory-developed Testing Revenue 2017-2028 (US$ Million)
Figure 19. North America Laboratory-developed Testing Revenue Market Share by Type (2017-2022)
Figure 20. North America Laboratory-developed Testing Revenue Market Share by Application (2017-2022)
Figure 21. Asia-Pacific Laboratory-developed Testing Revenue 2017-2028 (US$ Million)
Figure 22. Asia-Pacific Laboratory-developed Testing Revenue Market Share by Region (2017-2028)
Figure 23. Asia-Pacific Laboratory-developed Testing Revenue Market Share by Type (2017-2022)
Figure 24. Asia-Pacific Laboratory-developed Testing Revenue Market Share by Application (2017-2022)
Figure 25. Europe Laboratory-developed Testing Revenue Growth Rate 2017-2028 (US$ Million)
Figure 26. Europe Laboratory-developed Testing Revenue Market Share by Country (2017-2028)
Figure 27. Europe Laboratory-developed Testing Revenue Market Share by Type (2017-2022)
Figure 28. Europe Laboratory-developed Testing Revenue Market Share by Application (2017-2022)
Figure 29. Latin America Laboratory-developed Testing Revenue Growth Rate 2017-2028 (US$ Million)
Figure 30. Latin America Laboratory-developed Testing Revenue Market Share by Country (2017-2022)
Figure 31. Latin America Laboratory-developed Testing Revenue Market Share by Type (2017-2022)
Figure 32. Latin America Laboratory-developed Testing Revenue Market Share by Application (2017-2022)
Figure 33. Middle East and Africa Laboratory-developed Testing Revenue Growth Rate 2017-2028 (US$ Million)
Figure 34. Middle East and Africa Laboratory-developed Testing Revenue Market Share by Country (2017-2028)
Figure 35. Middle East and Africa Laboratory-developed Testing Revenue Market Share by Type (2017-2022)
Figure 36. Middle East and Africa Laboratory-developed Testing Revenue Market Share by Application (2017-2022)
Figure 37. Laboratory-developed Testing Supply Chain (Upstream and Downstream Market)
Figure 38. Global Production Market Share of Laboratory-developed Testing Raw Materials by Region in 2021
Figure 39. Laboratory-developed Testing Distribution Channels
Figure 40. Global Laboratory-developed Testing Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 41. Global Laboratory-developed Testing Percentage 2017-2028: Online Sales VS Offline Sales
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed
  • Global Viral Inactivation Kits Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 29-Nov-2022        Price: US 5600 Onwards        Pages: 115
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Viral Inactivation Kits is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China market ......
  • 2022-2027 Vietnam Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2022 Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
    Published: 28-Nov-2022        Price: US 1450 Onwards        Pages: 0
    This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years. The repo......
  • 2022-2027 Venezuela Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2022 Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
    Published: 28-Nov-2022        Price: US 1450 Onwards        Pages: 0
    This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years. The repo......
  • 2022-2027 Uruguay Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2022 Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
    Published: 28-Nov-2022        Price: US 1450 Onwards        Pages: 0
    This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years. The repo......
  • 2022-2027 United Arab Emirates Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2022 Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
    Published: 28-Nov-2022        Price: US 1450 Onwards        Pages: 0
    This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years. The repo......
  • 2022-2027 Ukraine Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2022 Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
    Published: 28-Nov-2022        Price: US 1450 Onwards        Pages: 0
    This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years. The repo......
  • 2022-2027 Turkey Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2022 Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
    Published: 28-Nov-2022        Price: US 1450 Onwards        Pages: 0
    This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years. The repo......
  • 2022-2027 Thailand Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2022 Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
    Published: 28-Nov-2022        Price: US 1450 Onwards        Pages: 0
    This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years. The repo......
  • 2022-2027 Taiwan Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--2022 Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
    Published: 28-Nov-2022        Price: US 1450 Onwards        Pages: 0
    This new report from LeadingMarketResearch.com is available by market segment, section, individual marker, and can be customized to specific information needs and budget. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years. The repo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs